Skip to main content

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 10, Number 10, October 2009

Articles

First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Multiple Myeloma Working Party Perspective
pp. 906-922(17)
Authors: Musto, Pellegrino; D'Auria, Fiorella; Pietrantuono, Giuseppe; Baldini, Luca; Bringhen, Sara; Caravita, Tommaso; Di Raimondo, Francesco; Morabito, Fortunato; Offidani, Massimo; Petrucci, Maria T.; Tosi, Patrizia; Gay, Francesca; Cavo, Michele; Boccadoro, Mario; Palumbo, Antonio

Favourites:
ADD

Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
pp. 923-936(14)
Authors: Gualberto, Antonio; Pollak, Michael

Favourites:
ADD

Targeting Sarcomas: Novel Biological Agents and Future Perspectives
pp. 937-949(13)
Authors: Mahalingam, Devalingam; Mita, Alain; Sankhala, Kamalesh; Swords, Ronan; Kelly, Kevin; Giles, Francis; Mita, Monica M.

Favourites:
ADD

Drug Targeting Through Pilosebaceous Route
pp. 950-967(18)
Authors: Chourasia, Rashmi; Jain, Sanjay K.

Favourites:
ADD

Proteasome Inhibitors in Cancer Therapy
pp. 968-981(14)
Author: Testa, Ugo

Favourites:
ADD

Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies
pp. 982-1000(19)
Authors: Chiuri, Vincenzo E.; Silvestris, Nicola; Tinelli, Andrea; Lorusso, Vito

Favourites:
ADD

Free Content Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation
pp. 1001-1008(8)
Authors: Dominguez-Rodriguez, A.; Abreu-Gonzalez, P.; Kaski, J. C.

Favourites:
ADD

The Paradox of Caffeine-Zolpidem Interaction: A Network Analysis
pp. 1009-1020(12)
Author: Myslobodsky, Michael

Favourites:
ADD

Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model
pp. 1021-1027(7)
Authors: Pastorino, F.; Di Paolo, D.; Loi, M.; Becherini, P.; Caffa, I.; Zorzoli, A.; Marimpietri, D.; Carosio, R.; Perri, P.; Montaldo, P. G.; Brignole, C.; Pagnan, G.; Ribatti, D.; Allen, T. M.; Ponzoni, M.

Favourites:
ADD

Down with the Erythropoietin. Long Live the Erythropoietin !
pp. 1028-1032(5)
Authors: Buemi, Michele; Lacquaniti, Antonio; Bolignano, Davide; Cernaro, Valeria; Campo, Susanna; Grasso, Giovanni; Buemi, Antoine; Donato, Valentina; Sturiale, Alessio

Favourites:
ADD

Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
pp. 1033-1040(8)
Authors: Meriggi, F.; Di Biasi, B.; Abeni, C.; Zaniboni, A.

Favourites:
ADD

Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options
pp. 1041-1048(8)
Authors: Maltezou, Helen C.; Tsiodras, Sotirios

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more